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Cerebrospinal fluid specimens from 57 patients diag-
nosed with meningitis were tested for Japanese encephali-
tis virus. Total RNA was extracted from the specimens and
amplified. Two products had highest homology with
Nakayama strain and 2 with Ishikawa strain. Results sug-
gest that Japanese encephalitis virus causes some aseptic
meningitis in Japan. 
J
apanese encephalitis virus is one of the leading causes
of epidemic encephalitis worldwide; 35,000–50,000
cases are reported each year with 10,000 deaths (1). Before
1960, >1,000 Japanese encephalitis cases were reported
annually in Japan. Because the Japanese encephalitis
immunization program was introduced ≈30 years ago, and
because of changes in rice farming, the annual number of
Japanese encephalitis cases has decreased dramatically.
Fewer than 10 Japanese encephalitis cases have been
reported annually since 1990 (2). During the past 10 years,
only 3 Japanese encephalitis cases have been reported in
Hiroshima prefecture, the western part of the main island
of Japan (Figure 1); all of these cases were reported in
2002 (2,3). 
Japanese encephalitis virus causes meningitis as well as
encephalitis (4). However, physicians tend not to list
Japanese encephalitis virus as a cause of meningitis. In this
study, we examined cerebrospinal fluid (CSF) specimens
from patients with aseptic meningitis for Japanese
encephalitis virus genome.
The Study
CSF specimens were obtained for diagnostic purposes
from 170 patients with a clinical diagnosis of aseptic
meningitis from August to October in each year from 1999
to 2002, in Hiroshima prefecture. These CSF specimens
were sent to the Division of Microbiology II, Hiroshima
Prefectural Institute of Health and Environment, for viro-
logic examination. Viruses were isolated from 112 of 170
CSF specimens in cell cultures by using Vero cells, BGM
cells, FL cells, Hep2 cells, and RD18S cells. Enteroviruses
and mumps viruses were isolated from 96 and 16 CSF
specimens, respectively (see online Appendix Table, avail-
able from http://www.cdc.gov/ncidod/eid/04-0285_app
.htm). Thus, etiologic agents were not determined for 58
meningitis cases. CSF specimens from 57 of these 58 cases
were used to detect Japanese encephalitis virus genome.
Whether the 57 patients had been vaccinated for Japanese
encephalitis virus was not known.
Total RNAwas extracted from CSF by using ISOGEN-
LS (Nippon Gene, Tokyo, Japan). The RNA pellet was
resuspended in DEPC Treated Water (Invitrogen Corp.,
Carlsbad, CA, USA). The RNA was reverse transcribed
and amplified by using polymerase chain reaction (PCR)
with AMV Reverse Transcriptase XL (Life Sciences Inc.,
St. Petersburg, Florida, USA.) and Tth DNA Polymerase
(Toyobo Co., Ltd., Osaka, Japan) with the primer pair
reported by Morita et al. (5). The PCR product was nested
PCR-amplified by TaKaRa EX Taq (Takara Bio Inc., Otsu,
Japan), with the primer pairs for E gene region reported by
Kimura et al. (6); JEN_ATC GTG GTT GGG AGG GGA
GA(1147-1166)_JENR_AGC ACA CCT CCT GTG GCT
AA(1472-1453). The DNA amplicons were separated by
electrophoresis on 1.5% (wt/vol) agarose gel, followed by
staining with ethidium bromide (1 µg/mL). The target
band detected by electrophoresis was purified by using the
Qiagen gel extraction kit (QIAGEN Inc., Valencia, CA,
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Figure 1. Location of Hiroshima prefecture in Japan and the areas
where patients 1-4 resided. Numbers 1-4 correspond to the
patients' numbers.USA). Purified cDNA was directly sequenced in both
directions by using the sense and the antisense primers
JEN and JENR. The samples that could not be sequenced
using these primers were reverse transcribed and PCR-
amplified, nested PCR-amplified, and directly sequenced
by using other primers designed to amplify the Japanese
encephalitis virus E gene region; RT-PCR JEen37s-first:
AAG GAG CCA GTG GAG CCA CTT, JEen329c-first:
TTC CCG AAA AGT CCA CAT CC, nested PCR and
sequence JEen98s-second: CAT GGC AAA CGA CAA
ACC AAC, JEen301c-second: CAG TRAAGC CTT GTT
TGC ACA C. The samples that could not be directly
sequenced by using the second primer sets were amplified
with nested PCR and sequenced by using JEen98s-second
and JEen271r-inner (RGT RAA GCC TTG TTT GCA
CAC).
Electrophoresis demonstrated the band with expected
size of 326 bp in 4 of 57 PCR products (Figure 1). Two
(numbers 1 and 2) of these products were sequenced on
326 bp and 247 bp, respectively, and the highest homolo-
gy was with Japanese encephalitis virus, Nakayama strain
(genotype III). PCR products 3 and 4 were sequenced on
121 bp and 187 bp by using other primers, and the highest
homology was with Japanese encephalitis virus, Ishikawa
strain (genotype I) (Table 1). 
Patients 1–4 lived in Hiroshima prefecture (Figure 2).
Patient 1 was a 3-year-old boy and patient 4 was a 6-year-
old girl (Table 2). They became sick in early August 2000.
Patient 2 was a 2-year-old girl who became sick in late
August 2000. Patient 3 was a 4-year-old boy who got sick
in mid-September 2000. CSF samples were obtained 2–3
days after the onset of illness. All 4 patients had symptoms
characteristic of meningitis and were clinically diagnosed
with meningitis.
Conclusions
Enteroviruses are the most frequent cause of aseptic
meningitis in summer and autumn in Japan (online
Appendix Table). In the CSF samples from these 4
patients, however, enteroviruses were not found. Watt et al.
reported that in Thailand, 14% of adult patients with acute,
undifferentiated fever had a diagnosis of Japanese
encephalitis virus infection because anti–Japanese
encephalitis virus immunoglobulin (Ig) M antibodies were
found (10). Many physicians in Japan consider Japanese
encephalitis virus to be mainly associated with encephali-
tis, and examination for the virus is not usually conducted
for patients with meningitis or undifferentiated fevers. 
Three Japanese encephalitis cases occurred in 2002 for
the first time in 12 years, but anti–Japanese encephalitis
virus IgM antibodies were detected in porcine serum sam-
ples every year in Hiroshima prefecture (data not shown).
So we expected that Japanese encephalitis virus might be
associated with aseptic meningitis, and CSF specimens
from 57 cases during the past 5 years (1998–2002) had
been stored at –30°C in Hiroshima Prefectural Institute of
Health and Environment. Those specimens were used to
detect Japanese encephalitis virus genome retrospectively.
Four of 57 CSF samples were Japanese encephalitis virus
genome–positive by nested PCR. We may find more
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Figure 2. Detection of the Japanese encephalitis virus E gene in
cerebrospinal fluid from patients with meningitis. Lanes 1–4,
patients 1–4; lane P, positive control (JaGAr#01); lane M, marker
(100-bp ladder)febrile or meningitis cases caused by Japanese encephali-
tis virus if we routinely conduct serologic or molecular
diagnostic tests for Japanese encephalitis virus. CSF sam-
ples were from infants and children. Most Japanese
encephalitis patients in Japan are >55 years of age.
Japanese encephalitis meningitis may also occur among
elderly meningitis patients. The Japanese encephalitis vac-
cination coverage of children has been decreasing in Japan
recently;  <10 Japanese encephalitis cases are reported
annually. If the general population recognizes that
Japanese encephalitis virus causes aseptic meningitis at a
higher rate than expected, the percentage of Japanese
encephalitis vaccination may increase, and the emergence
of Japanese encephalitis will be prevented. In 2000,
anti–Japanese encephalitis virus IgM antibody was first
detected in porcine serum samples in late July, in
Hiroshima prefecture (data not shown). This finding sug-
gests that Japanese encephalitis virus was active when
these 4 meningitis cases occurred. Further, we found evi-
dence that Japanese encephalitis viruses belonging to
genotypes I and III were active in Hiroshima prefecture
(data not shown). The results of this study suggest that
Japanese encephalitis virus should be considered in the dif-
ferential diagnosis of aseptic meningitis in areas where
Japanese encephalitis is endemic or epidemic.
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